Wilson Marc 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 6, 2024
Insider Transaction Report
Form 4
Wilson Marc
CFO
Transactions
- Award
Stock Option (right to buy)
2024-03-04+95,500→ 95,500 totalExercise: $43.51Exp: 2034-03-03→ Common Stock (95,500 underlying) - Award
Common Stock
2024-03-04+25,500→ 121,555 total
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2025.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 4, 2024.